Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CervoMed Inc.DFFN · Entity 7338 | Director | July 01, 2021 | July 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CervoMed Inc.
Report date July 01, 2021 · Filed July 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.72 · Expires 2031-07-01 | Direct | 83,300 |
Reported balance
After 2021-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-01 · Grant · Acquired 83,300 · Balance 83,300 F1: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016510 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 20:53 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 61,300 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001437749-20-013423 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,300 Underlying: Common Stock · 61,300 shares Expires 2030-06-17 F1 · derivative.exercise_date: The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on June 17, 2020. Read SEC document |
| June 13, 2019 Filed Jul 19, 2019 19:01 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 13,100 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001437749-19-014279 · rdgdoc.xml · derivative · entry 3 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 Underlying: Common Stock · 13,100 shares Expires 2029-06-13 F1 · derivative.exercise_date: The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on June 13, 2019. Read SEC document |
| June 13, 2019 Filed Aug 6, 2019 12:53 UTC Amendment | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 19,200 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001437749-19-015541 · rdgdoc.xml · derivative · entry 3 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,200 Underlying: Common Stock · 19,200 shares Expires 2029-06-13 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:37 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001437749-18-012015 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-06-14 F1 · derivative.exercise_date: The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments over a one-year period beginning on the grant date, provided that the final tranche will vest on the day immediately prior to the subsequent annual meeting. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:01 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001437749-18-000257 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on January 31, 2018. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 21:29 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 23,900 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001437749-17-011436 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,900 Underlying: Common Stock · 23,900 shares Expires 2027-06-15 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the fifteenth day of each month until fully vested on June 15, 2018. Read SEC document |
| December 08, 2016 Filed Dec 13, 2016 21:27 UTC | CervoMed Inc. DFFN · Entity 7338 | GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001437749-16-043298 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2026-12-08 F1 · derivative.exercise_date: The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on November 30, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.